You are here

Merck

Merck: Enjoy This Generous Yield

Seeking Alpha

Tue, 02/19/13 - 09:46 am

Merck's Weakest Blockbuster?

Motley Fool

Tue, 02/19/13 - 09:41 am

rheumatoid arthritis

Does the Arthritis Market Have Growing Pains?

Motley Fool

Sun, 02/17/13 - 11:51 am

rheumatoid arthritis

Merck Finally Settles Over Vytorin

Seeking Alpha

Sat, 02/16/13 - 11:54 am

Better Dividend: Merck or Pfizer?

Motley Fool

Sat, 02/16/13 - 11:53 am

Merck's Dynamic Duo

Motley Fool

Fri, 02/15/13 - 10:42 am

Merck To Pay $688 Million To Shareholders For Delaying Vytorin Results

Forbes

Thu, 02/14/13 - 09:57 am

Merck's Crash of a Titan

Motley Fool

Wed, 02/13/13 - 10:29 am

Merck Cuts First-Quarter Forecast on Venezuela Currency

Bloomberg

Wed, 02/13/13 - 10:28 am

Five Super Ideas in the Healthcare Sector

Motley Fool

Wed, 02/13/13 - 10:21 am

Seattle Genetics

Promising insomnia pill from Merck remains 'critical' to future amid recent setbacks

Newark Star-Ledger, NJ

Mon, 02/11/13 - 08:19 am

Merck's Fight for Fat Profits

Motley Fool

Sat, 02/9/13 - 12:03 pm

Merck loses 'bellwether' Fosamax case

Fierce Pharma

Wed, 02/6/13 - 11:12 am

Big Pharma's Uphill 2013 Battle

Motley Fool

Wed, 02/6/13 - 11:02 am

Bristol-Myers Squibb

What Will Type 2 Diabetes Treatments Look Like in 5 Years?

Motley Fool

Wed, 02/6/13 - 08:34 am

SGLT2 inhibitor

Bristol-Myers Squibb

Array Biopharma

Not Working Out So Well At Merck?

Seeking Alpha

Tue, 02/5/13 - 06:10 pm

Aspen Pharmacare In Talks to Buy Merck & Co. Dutch Unit

Bloomberg

Mon, 02/4/13 - 11:25 am

Aspen Pharmacare

Merck Earnings Call Nuggets: Outcome of IMPROVE-IT and Filing Odanacatib

Wall Street Cheat Street

Sun, 02/3/13 - 11:59 am

Merck Earnings: Exceeding Estimates Not Enough to Impress

Wall St. Cheat Sheet

Fri, 02/1/13 - 11:03 am

Merck says now anticipates odanacatib filing in 2014

Yahoo/Fly on the Wall

Fri, 02/1/13 - 10:55 am

Pages